S&P Sees Mild Weekly Gain, Nasdaq Outperforms As Biotech Shines

The S&P finished the week mildly higher than where it began though the Nasdaq had a winning week as the bounceback in mega-cap tech names continued and the biotech sector saw new found strength.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.